JP2025510369A5 - - Google Patents
Info
- Publication number
- JP2025510369A5 JP2025510369A5 JP2024557759A JP2024557759A JP2025510369A5 JP 2025510369 A5 JP2025510369 A5 JP 2025510369A5 JP 2024557759 A JP2024557759 A JP 2024557759A JP 2024557759 A JP2024557759 A JP 2024557759A JP 2025510369 A5 JP2025510369 A5 JP 2025510369A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- dose
- dmt
- meo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22000083.0 | 2022-03-27 | ||
| EP22000086 | 2022-03-27 | ||
| EP22000086.3 | 2022-03-27 | ||
| EP22000083 | 2022-03-27 | ||
| EP23153995.8 | 2023-01-30 | ||
| EP23153939 | 2023-01-30 | ||
| EP23153995 | 2023-01-30 | ||
| EP23153939.6 | 2023-01-30 | ||
| PCT/EP2023/057876 WO2023186829A1 (en) | 2022-03-27 | 2023-03-27 | 5-methoxy-n,n-dimethyltryptamine for the treatment of social/emotional withdrawal or detachment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025510369A JP2025510369A (ja) | 2025-04-14 |
| JP2025510369A5 true JP2025510369A5 (enExample) | 2026-04-06 |
Family
ID=86007166
Family Applications (6)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557191A Pending JP2025510912A (ja) | 2022-03-27 | 2023-03-27 | 双極性障害を処置するための５－メトキシ－ｎ，ｎ－ジメチルトリプタミン |
| JP2024557759A Pending JP2025510369A (ja) | 2022-03-27 | 2023-03-27 | 社会的／情動的引きこもりまたは離隔の処置のための５－メトキシ－ｎ，ｎ－ジメチルトリプタミン |
| JP2024557755A Pending JP2025511081A (ja) | 2022-03-27 | 2023-03-27 | 睡眠障害の治療における使用のための５－ＭｅＯ－ＤＭＴ |
| JP2024557758A Pending JP2025510368A (ja) | 2022-03-27 | 2023-03-27 | 不安の処置 |
| JP2024557205A Pending JP2025510916A (ja) | 2022-03-27 | 2023-03-27 | 精神運動遅滞の治療のための５－メトキシ－ｎ，ｎ－ジメチルトリプタミン |
| JP2024557204A Pending JP2025512831A (ja) | 2022-03-27 | 2023-03-27 | 認知機能障害の治療 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557191A Pending JP2025510912A (ja) | 2022-03-27 | 2023-03-27 | 双極性障害を処置するための５－メトキシ－ｎ，ｎ－ジメチルトリプタミン |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024557755A Pending JP2025511081A (ja) | 2022-03-27 | 2023-03-27 | 睡眠障害の治療における使用のための５－ＭｅＯ－ＤＭＴ |
| JP2024557758A Pending JP2025510368A (ja) | 2022-03-27 | 2023-03-27 | 不安の処置 |
| JP2024557205A Pending JP2025510916A (ja) | 2022-03-27 | 2023-03-27 | 精神運動遅滞の治療のための５－メトキシ－ｎ，ｎ－ジメチルトリプタミン |
| JP2024557204A Pending JP2025512831A (ja) | 2022-03-27 | 2023-03-27 | 認知機能障害の治療 |
Country Status (9)
| Country | Link |
|---|---|
| US (9) | US20250241893A1 (enExample) |
| EP (7) | EP4499088A1 (enExample) |
| JP (6) | JP2025510912A (enExample) |
| KR (6) | KR20250005183A (enExample) |
| CN (2) | CN119095595A (enExample) |
| AU (6) | AU2023246774A1 (enExample) |
| CA (6) | CA3255348A1 (enExample) |
| IL (6) | IL315899A (enExample) |
| WO (9) | WO2023186820A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753923A1 (en) | 2019-06-19 | 2020-12-23 | GH Research Limited | Recrystallisation of 5-methoxy-n,n-dimethyltryptamine (5-meo-dmt) in methyl tert.-butyl ether (mtbe) without adding an anti-solvent |
| EP4155306A1 (en) | 2021-01-15 | 2023-03-29 | Beckley Psytech Limited | Neuroactive ergoline analogue |
| US12534441B2 (en) | 2021-01-15 | 2026-01-27 | Beckley Psytech Limited | Tryptamine analogues |
| US11312684B1 (en) | 2021-02-10 | 2022-04-26 | Eleusis Therapeutics Us, Inc. | Pharmaceutically acceptable salts of psilocin and uses thereof |
| US12264131B2 (en) | 2022-08-19 | 2025-04-01 | Beckley Psytech Limited | Pharmaceutically acceptable salts and compositions thereof |
| GB202306256D0 (en) * | 2023-04-27 | 2023-06-14 | Beckley Psytech Ltd | 5-Methoxy-N,N-Dimethyltryptamine Formulations |
| US12246005B2 (en) | 2023-06-13 | 2025-03-11 | Beckley Psytech Limited | 5-methoxy-n,n-dimethyltryptamine (5-MeO-DMT) formulations |
| WO2026078143A1 (en) | 2024-10-09 | 2026-04-16 | GH Research Ireland Limited | Combinations of 5-meo-dmt with antidepressants for treating depression |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19803376C1 (de) | 1998-01-29 | 1999-10-14 | Markus Storz | Inhalator zur Erzeugung von aroma- und/oder wirkstoffhaltigen Dämpfen aus Pflanzenmaterial und/oder Flüssigkeiten |
| US20030051728A1 (en) | 2001-06-05 | 2003-03-20 | Lloyd Peter M. | Method and device for delivering a physiologically active compound |
| US7458374B2 (en) | 2002-05-13 | 2008-12-02 | Alexza Pharmaceuticals, Inc. | Method and apparatus for vaporizing a compound |
| US20040234916A1 (en) | 2003-05-21 | 2004-11-25 | Alexza Molecular Delivery Corporation | Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same |
| ES2355983T3 (es) | 2006-08-01 | 2011-04-01 | STOBI GMBH & CO. KG | Balón de válvula para inhaladores . |
| MA50786A (fr) * | 2017-10-26 | 2022-04-27 | Blumentech S L | Produit d'association pour le traitement de troubles neurologiques et/ou psychiatriques |
| FI4349407T3 (fi) | 2019-02-22 | 2025-06-02 | Gh Res Ireland Limited | 5-metoksi-n,n-dimetyylitryptamiini (5-meo-dmt) vaikean masennuksen hoitoon |
| HUE069534T2 (hu) * | 2019-02-22 | 2025-03-28 | Gh Res Ireland Limited | 5-Metoxi-N,N-dimetiltriptamint (5-MeO-DMT) tartalmazó készítmény mentális rendellenességek kezelésében történõ alkalmazásra |
| US12377112B2 (en) * | 2019-04-17 | 2025-08-05 | Compass Pathfinder Limited | Methods of treating neurocognitive disorders, chronic pain and reducing inflammation |
| EP3868364A1 (en) * | 2020-02-24 | 2021-08-25 | GH Research Limited | Aerosol comprising 5-methoxy-n,n-dimethyltryptamine |
| WO2021216489A1 (en) * | 2020-04-20 | 2021-10-28 | Lobe Sciences Ltd. | Methods for treating mild traumatic brain injury, post traumatic stress disorder and mild traumatic brain injury |
| BR112022025306A2 (pt) * | 2020-06-12 | 2023-02-28 | Beckley Psytech Ltd | Composição compreendendo um sal benzoato de 5-metóxin, n-dimetiltriptamina |
| US11406619B2 (en) * | 2020-08-28 | 2022-08-09 | Small Pharma Ltd | Injectable formulations |
| US20240299353A1 (en) | 2021-03-12 | 2024-09-12 | Alvarius Pharmaceuticals Ltd. | Compositions and methods for treating addictions comprising 5-meo-dmt |
-
2023
- 2023-03-27 IL IL315899A patent/IL315899A/en unknown
- 2023-03-27 CA CA3255348A patent/CA3255348A1/en active Pending
- 2023-03-27 WO PCT/EP2023/057867 patent/WO2023186820A1/en not_active Ceased
- 2023-03-27 EP EP23717412.3A patent/EP4499088A1/en active Pending
- 2023-03-27 CA CA3255340A patent/CA3255340A1/en active Pending
- 2023-03-27 KR KR1020247035762A patent/KR20250005183A/ko active Pending
- 2023-03-27 US US18/850,376 patent/US20250241893A1/en active Pending
- 2023-03-27 AU AU2023246774A patent/AU2023246774A1/en active Pending
- 2023-03-27 KR KR1020247035758A patent/KR20250005181A/ko active Pending
- 2023-03-27 IL IL315902A patent/IL315902A/en unknown
- 2023-03-27 WO PCT/EP2023/057870 patent/WO2023186823A1/en not_active Ceased
- 2023-03-27 EP EP23717035.2A patent/EP4499075A1/en active Pending
- 2023-03-27 WO PCT/EP2023/057857 patent/WO2023186816A1/en not_active Ceased
- 2023-03-27 AU AU2023242291A patent/AU2023242291A1/en active Pending
- 2023-03-27 IL IL315898A patent/IL315898A/en unknown
- 2023-03-27 IL IL315891A patent/IL315891A/en unknown
- 2023-03-27 KR KR1020247035718A patent/KR20250005176A/ko active Pending
- 2023-03-27 EP EP23717036.0A patent/EP4499076A1/en not_active Withdrawn
- 2023-03-27 WO PCT/EP2023/057842 patent/WO2023186806A1/en not_active Ceased
- 2023-03-27 CA CA3255505A patent/CA3255505A1/en active Pending
- 2023-03-27 WO PCT/EP2023/057877 patent/WO2023186830A1/en not_active Ceased
- 2023-03-27 US US18/851,346 patent/US20250241895A1/en active Pending
- 2023-03-27 CA CA3255629A patent/CA3255629A1/en active Pending
- 2023-03-27 KR KR1020247035659A patent/KR20240167879A/ko active Pending
- 2023-03-27 EP EP23717033.7A patent/EP4499073A1/en active Pending
- 2023-03-27 WO PCT/EP2023/057883 patent/WO2023186835A1/en not_active Ceased
- 2023-03-27 JP JP2024557191A patent/JP2025510912A/ja active Pending
- 2023-03-27 JP JP2024557759A patent/JP2025510369A/ja active Pending
- 2023-03-27 AU AU2023246543A patent/AU2023246543A1/en active Pending
- 2023-03-27 EP EP23717042.8A patent/EP4499082A1/en active Pending
- 2023-03-27 US US18/850,383 patent/US20250205256A1/en not_active Abandoned
- 2023-03-27 JP JP2024557755A patent/JP2025511081A/ja active Pending
- 2023-03-27 JP JP2024557758A patent/JP2025510368A/ja active Pending
- 2023-03-27 US US18/850,362 patent/US20250241892A1/en active Pending
- 2023-03-27 CN CN202380030914.XA patent/CN119095595A/zh active Pending
- 2023-03-27 IL IL315897A patent/IL315897A/en unknown
- 2023-03-27 IL IL315896A patent/IL315896A/en unknown
- 2023-03-27 WO PCT/EP2023/057876 patent/WO2023186829A1/en not_active Ceased
- 2023-03-27 CA CA3255343A patent/CA3255343A1/en active Pending
- 2023-03-27 CA CA3255648A patent/CA3255648A1/en active Pending
- 2023-03-27 AU AU2023244452A patent/AU2023244452A1/en active Pending
- 2023-03-27 KR KR1020247035746A patent/KR20250005179A/ko active Pending
- 2023-03-27 JP JP2024557205A patent/JP2025510916A/ja active Pending
- 2023-03-27 US US18/850,348 patent/US20250241891A1/en active Pending
- 2023-03-27 WO PCT/EP2023/057827 patent/WO2023186797A1/en not_active Ceased
- 2023-03-27 EP EP23717031.1A patent/EP4499226A1/en active Pending
- 2023-03-27 EP EP23717043.6A patent/EP4499083A1/en active Pending
- 2023-03-27 US US18/851,343 patent/US20250213532A1/en active Pending
- 2023-03-27 AU AU2023246545A patent/AU2023246545A1/en active Pending
- 2023-03-27 US US18/850,370 patent/US20250205199A1/en active Pending
- 2023-03-27 AU AU2023246679A patent/AU2023246679A1/en active Pending
- 2023-03-27 KR KR1020247035653A patent/KR20250005170A/ko active Pending
- 2023-03-27 WO PCT/EP2023/057873 patent/WO2023186826A1/en not_active Ceased
- 2023-03-27 JP JP2024557204A patent/JP2025512831A/ja active Pending
- 2023-03-27 CN CN202380031464.6A patent/CN119053327A/zh active Pending
- 2023-09-27 US US18/373,903 patent/US20240108601A1/en active Pending
- 2023-09-27 US US18/373,906 patent/US20240108602A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025510369A5 (enExample) | ||
| JP2025510368A5 (enExample) | ||
| JP2025510295A5 (enExample) | ||
| JP2025512831A5 (enExample) | ||
| JP2025511081A5 (enExample) | ||
| JP2025510916A5 (enExample) | ||
| JP2025511084A5 (enExample) | ||
| JP2025510912A5 (enExample) | ||
| US6335021B1 (en) | Composition for controlling mood disorders in healthy individuals | |
| JP2025510296A5 (enExample) | ||
| JP2025510913A5 (enExample) | ||
| JP2017503801A (ja) | 小児における急性呼吸促迫症候群の治療のための吸入一酸化窒素ガスを使用する方法 | |
| JP2021527092A5 (enExample) | ||
| Takasaki et al. | Dexmedetomidine facilitates induction of noninvasive positive pressure ventilation for acute respiratory failure in patients with severe asthma | |
| JPH05170647A (ja) | 睡眠中の換気を改善する方法および睡眠に係る換気異常を処置する方法 | |
| Francis | Long-term beclomethasone dipropionate aerosol therapy in juvenile asthma. | |
| JP2022521233A5 (enExample) | ||
| JP2020015687A (ja) | 統合失調症治療用組成物 | |
| BR112020005856A2 (pt) | uso de uma composição contendo benzoato para tratar encefalopatia da glicina | |
| Yokoe et al. | A prospective, randomized controlled trial of conscious sedation using propofol combined with inhaled nitrous oxide for dental treatment | |
| JP7369523B2 (ja) | 中等度～重度のインフルエンザの処置 | |
| JP2023537369A5 (enExample) | ||
| JP2022504435A5 (enExample) | ||
| Long | Effect of phenylhydrazine derivatives in the treatment of polycythemia | |
| JP2012031141A (ja) | 骨髄異形性症候群を治療するための組成物および方法 |